Home Medicine Development and linear growth in diabetic children receiving insulin pigment
Article
Licensed
Unlicensed Requires Authentication

Development and linear growth in diabetic children receiving insulin pigment

  • Li Mao , Weiping Lu EMAIL logo , Feng Ji and Shujun Lv
Published/Copyright: August 1, 2011

Abstract

Objective: The aim of this study was to ascertain if there are differences in the development and linear growth between a group of diabetic children who had been receiving insulin pigment and healthy children.

Methods: A total of 57 Chinese children with type 1 diabetes diagnosed at the age from 6 to 10 years old (26 boys and 31 girls) were included in the study. Their height and weight and development conditions were recorded until they reached their 18th birthday.

Results: Diabetic children were taller than healthy children at the onset of diabetes, even though there was no significant difference between them [male height standard deviation score (SDS): 0.34±0.93, female height SDS: 0.38±0.50]. When they reached their final height, they were slightly shorter than the healthy group. However, there were still no significant differences between these two groups (male height SDS: –0.42±0.95, female height SDS: –0.60±0.98). The median age at onset of puberty, 12.62 years in boys and 11.13 years in girls, was significantly delayed in diabetic boys compared to 10.55 years in healthy boys and 9.2 years in healthy girls. The median age at menarche in diabetic girls (14.15 years) was also delayed compared with 12.27 years in healthy girls. The majority of these diabetic children were thinner than the healthy children when they were diagnosed [male body mass index (BMI): 14.45±1.35 kg/m2vs. 16.08±0.59 kg/m2, t=–0.63, p<0.05; female BMI: 13.50±1.87 kg/m2vs. 15.46±0.45 kg/m2, t=–6.67, p<0.05]; however, as they reached their final height, they became fatter, especially the girls (male BMI: 21.43±1.62 kg/m2vs. 20.8±0.00 kg/m2, t=1.97, p>0.05; female BMI: 23.95±2.37 kg/m2vs. 20.3±0.00 kg/m2, t=8.60, p<0.05).

Conclusion: Even with well-controlled glucose levels, the development of children with diabetes who had been receiving insulin pigment were still adversely affected. However, linear growth had only been slightly affected. All patients, especially girls, became fatter when they reached their final height.


Corresponding author: Weiping Lu, Department of Endocrinology, Huaian No. 1 People’s Hospital Affi liated to Nanjing Medical University, Beijingxilu 6, Huaian City, Jiangsu Province, China Phone: +086-517-80872628, Fax: +086-517-84922412

Published Online: 2011-08-01
Published in Print: 2011-08-01

©2011 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorial
  2. Pitfalls for bone age measurement
  3. Bone disease and cytokines in idiopathic hypercalciuria: a review
  4. Cord blood adiponectin and infant growth at one year
  5. Plasma visfatin and adiponectin concentrations in physically active adolescent girls: relationships with insulin sensitivity and body composition variables
  6. Gender differences exist in the association of leptin and adiponectin levels with insulin resistance parameters in prepubertal Arab children
  7. Development and linear growth in diabetic children receiving insulin pigment
  8. Genotypes of p53 codon 72 correlate with age at onset of type 1 diabetes in a sex-specific manner
  9. A prospective clinical pilot-trial comparing the effect of an optimized mixed diet versus a flexible low-glycemic index diet on nutrient intake and HbA1c levels in children with type 1 diabetes
  10. Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study
  11. Short communication
  12. Italian pediatric data support hypothesis that simultaneous epidemics of type 1 diabetes and type 2 diabetes/metabolic syndrome/obesity are polar opposite responses (i.e., symptoms) to a primary inflammatory condition
  13. Adult height after growth hormone treatment in Japanese children with idiopathic growth hormone deficiency: analysis from the KIGS Japan database
  14. Growth patterns of large, small, and appropriate for gestational age infants: impacts of long-term breastfeeding: a retrospective cohort study
  15. Body image and sexual interests in adolescents and young adults with Prader–Willi syndrome
  16. Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome
  17. The effect of corrective surgery on serum IGF-1, IGFBP-3 levels and growth in children with congenital heart disease
  18. Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patients
  19. DXA surrogates for visceral fat are inversely associated with bone density measures in adolescent athletes with menstrual dysfunction
  20. Evaluation of bone density in girls with precocious and early puberty during treatment with GnRH agonist
  21. Comparative analysis of clinical, biochemical and genetic aspects associated with bone mineral density in small for gestational age children
  22. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand
  23. Ovarian function in adolescents with McCune-Albright syndrome
  24. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids – more common than expected?
  25. Clinical characteristics of adrenocortical tumors in children
  26. Preimplantation genetic diagnosis (PGD) – prevention of the birth of children affected with endocrine diseases
  27. The usefulness of ultrasound in follow-up of a patient with dyshormonogenetic congenital hypothyroidism
  28. Accelerated carpal bone maturation in juvenile idiopathic arthritis: pitfall for bone age measurement
  29. Case reports
  30. Hypokalaemic paralysis in a 15-year-old boy with 11β-hydroxylase deficiency
  31. Structural chromosome disruption of the NR3C2 gene causing pseudohypoaldosteronism type 1 presenting in infancy
  32. Continuous subcutaneous hydrocortisone infusion (CSHI) in a young adolescent with congenital adrenal hyperplasia (CAH)
  33. Causes and consequences of abandoning one-stage bilateral adrenalectomy recommended in primary pigmented nodular adrenocortical disease – case presentation
  34. Short stature in a patient with familial glucocorticoid deficiency
  35. Biochemical evaluation of an infant with hypoglycemia resulting from a novel de novo mutation of the GLUD1 gene and hyperinsulinism-hyperammonemia syndrome
  36. Entire prophet of Pit-1 (PROP-1) gene deletion in an Indian girl with combined pituitary hormone deficiencies
  37. Diabetes in young – unusual case presentation
  38. Patient reports
  39. Two cases of 22q11.2 deletion syndrome with anorectal anomalies and growth retardation
  40. A 3-year-old boy with ovotestes: gender reassignment and surgical management
  41. Case reports
  42. A 5-year-old boy with atrophic autoimmune thyroiditis caused by thyroid-stimulation blocking antibodies
  43. Small nuclear ribonucleoprotein polypeptide N quantitative methylation analysis in infants with central hypotonia
  44. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) due to AIRET16M mutation in a consanguineous Greek girl
  45. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide
  46. Commentary
  47. Using genetic tests for talent identification in sports: too soon to be true
  48. Letter to the Editors
  49. Insulin resistance and the metabolic syndrome in obese children
  50. Graves’ disease in a Down’s syndrome patient responds well to radioiodine rather than antithyroid drugs
  51. Aortic intima-media thickness and lipid profile in neonates born to mothers with pre-eclampsia: weak or strong relations?
  52. Meetings
  53. Meetings Calendar
Downloaded on 10.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem.2011.204/html
Scroll to top button